Literature DB >> 22218519

Epstein-Barr virus DNA load and its association with Helicobacter pylori infection in gastroduodenal diseases.

Sanket Kumar Shukla1, K N Prasad, Aparna Tripathi, Avinash Singh, Ashish Saxena, Uday Chand Ghoshal, Narendra Krishnani, Nuzhat Husain.   

Abstract

UNLABELLED: Helicobacter pylori and Epstein-Barr virus (EBV) infections are common worldwide. Although H. pylori infection is a major factor in gastroduodenal diseases, its role in association with EBV infection is unknown.
OBJECTIVE: To study the association of H. pylori infection and EBV DNA load in patients with gastroduodenal diseases.
METHODS: Biopsy samples were collected from 200 adult patients [non-ulcer dyspepsia (NUD) 100, peptic ulcer disease (PUD) 50, gastric carcinoma (GC) 50] undergoing upper gastrointestinal endoscopy. H. pylori infection was diagnosed by rapid urease test, culture, histopathology, PCR and Q-PCR. EBV DNA was detected by non-polymorphic Epstein-Barr nuclear antigen-1 (EBNA-1) gene based Q-PCR.
RESULTS: In patients with GC and PUD, EBV DNA was detected more often than NUD (GC versus NUD = 90% versus 37%, p < 0.001; PUD versus NUD = 70% versus 37%, p < 0.001). The dual prevalence of H. pylori infection and EBV DNA was significantly higher in patients with GC and PUD than in those with NUD. Median copy number of EBV DNA was considerably higher in GC and PUD than NUD (p < 0.01). The copy number of EBV DNA was significantly higher in H. pylori infected patients (p = 0.015). The number of ureA gene copies was also found to be significantly higher in PUD and NUD with presence of EBV DNA. However, in GC no significant difference was seen between EBV positive and negative status.
CONCLUSION: There was a trend for higher EBV DNA load in H. pylori positive individuals suggesting a probable role of H. pylori in modulating the conversion of EBV to its lytic phase.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22218519

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   1.949


  15 in total

1.  Co-infection with Helicobacter pylori and Epstein-Barr virus in benign upper digestive diseases: An endoscopic and serologic pilot study.

Authors:  György M Buzás; Judith Konderák
Journal:  United European Gastroenterol J       Date:  2015-10-13       Impact factor: 4.623

2.  Epstein-Barr virus infection is common in inflamed gastrointestinal mucosa.

Authors:  Julie L Ryan; You-Jun Shen; Douglas R Morgan; Leigh B Thorne; Shannon C Kenney; Ricardo L Dominguez; Margaret L Gulley
Journal:  Dig Dis Sci       Date:  2012-03-13       Impact factor: 3.199

3.  No Evidence for an Association between JC Polyomavirus Infection and Gastroduodenal Diseases.

Authors:  Azadeh Yazdani Cherati; Yousef Yahyapour; Mohammad Ranaee; Mehdi Rajabnia; Javad Shokri Shirvani; Mahmoud Hajiahmadi; Farzin Sadeghi
Journal:  Gastrointest Tumors       Date:  2018-07-11

4.  Epstein-Barr virus association with peptic ulcer disease.

Authors:  María G Cárdenas-Mondragón; Javier Torres; Lourdes Flores-Luna; Ricardo Carreón-Talavera; Margarita Camorlinga-Ponce; Ezequiel M Fuentes-Pananá
Journal:  Anal Cell Pathol (Amst)       Date:  2015-06-24       Impact factor: 2.916

Review 5.  Epstein-Barr Virus and Gastric Cancer Risk: A Meta-analysis With Meta-regression of Case-control Studies.

Authors:  Jong-Myon Bae; Eun Hee Kim
Journal:  J Prev Med Public Health       Date:  2016-03-04

Review 6.  Epstein-Barr virus infection and gastric cancer: a systematic review.

Authors:  Xin-Zu Chen; Hongda Chen; Felipe A Castro; Jian-Kun Hu; Hermann Brenner
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

7.  Aminophosphinates against Helicobacter pylori ureolysis-Biochemical and whole-cell inhibition characteristics.

Authors:  Katarzyna Macegoniuk; Ewa Grela; Monika Biernat; Mateusz Psurski; Grażyna Gościniak; Anna Dziełak; Artur Mucha; Joanna Wietrzyk; Łukasz Berlicki; Agnieszka Grabowiecka
Journal:  PLoS One       Date:  2017-08-09       Impact factor: 3.240

8.  Prevalence and characteristics of Epstein-Barr virus-associated gastric carcinomas in Portugal.

Authors:  Paulo Figueiredo; Maximino Leitão; Célia Nogueira; Marta Mota; Rui Gradiz; Maria Augusta Cipriano; Francisco Caramelo; Hugo Cruz; Ana Alarcão; Francisco Castro E Sousa; Fernando Oliveira; Fernando Martinho; João Moura Pereira
Journal:  Infect Agent Cancer       Date:  2017-07-19       Impact factor: 2.965

Review 9.  Status of Epstein-Barr Virus Coinfection with Helicobacter pylori in Gastric Cancer.

Authors:  Shyam Singh; Hem Chandra Jha
Journal:  J Oncol       Date:  2017-03-21       Impact factor: 4.375

10.  Helicobacter pylori genotypes associated with gastric histo-pathological damages in a Moroccan population.

Authors:  Samia Alaoui Boukhris; Afaf Amarti; Karima El Rhazi; Mounia El Khadir; Dafr-Allah Benajah; Sidi Adil Ibrahimi; Chakib Nejjari; Mustapha Mahmoud; Abdellah Souleimani; Bahia Bennani
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.